ArticleCancers2023
Correction: van de Velde et al. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial).
Mirjam Esther van de Velde, Gertjan J L Kaspers, Floor C H Abbink, Jos W R Twisk, Inge M van der Sluis, Cor van den Bos, Marry M van den Heuvel-Eibrink, Heidi Segers, Christophe Chantrain, Jutte van der Werff Ten Bosch and 2 more
Full text readPublished Erratum
In one paragraphArticle in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
12 authors.
Mirjam Esther van de VeldeEmma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0003-0424-2085 Gertjan J L KaspersEmma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0001-7716-8475 Floor C H AbbinkEmma Children's Hospital, Amsterdam UMC, Amsterdam Medical Center, Pediatric Oncology, 1105 AZ Amsterdam, The Netherlands.ORCID 0000-0002-4384-1454 Jos W R TwiskDepartment of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.
Inge M van der SluisPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-5822-7668 Cor van den BosPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Marry M van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Heidi SegersDepartment of Pediatric Hemato-Oncology, University Hospitals Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-3604-7850 Christophe ChantrainDepartment of Pediatrics, Clinique du MontLégia, CHC, 4000 Liège, Belgium.
Jutte van der Werff Ten BoschDepartment of Pediatric Onco-Hematology, Universitair Ziekenhuis Brussel, 1090 Brussels, Belgium.
Leen WillemsDepartment of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, 9000 Ghent, Belgium.ORCID 0000-0003-1230-1049 Marleen H van den BergEmma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Pediatric Oncology, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-6493-8482 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
In the original publication, there was a mistake in
Identifiers
PMID36900422
PMCPMC10000134
What OpenQuestion holds
Textfull text, public
LicenceCC BY
Read underepoch 390